Masitinib is an oral inhibitor of tyrosine kinases, enzymes important for immune cells thought to drive ALS inflammation and ...

Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.

Columnist Dagmar Munn turns to affirmations and positive self-talk on those occasional days when she feels shut down.

ALS is a disease of continual losses and trade-offs. We walk a tightrope between safety and independence, and caution and quality of life.

The genes included those involved in the function of energy-producing mitochondria, lipid and iron metabolism, and the ...

New York was the only state to receive the highest mark on the ALS Association’s latest report cards, the association said.

A 22-month survival benefit was seen for a subset of ALS patients whose disease did not progress when treated with NP001 in ...

I was enchanted on the first date with my late husband, Jeff, when our conversation turned to work. It’s an odd thing to say, because we can be conditioned to believe that work should be a less ...

Zydus Lifesciences has been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 2b trial testing its experimental oral treatment usnoflast in people with amyotrophic lateral ...